Latest Insider Transactions at Medifast Inc (MED)
This section provides a real-time view of insider transactions for Medifast Inc (MED). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEDIFAST INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEDIFAST INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2024
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
11
-0.28%
|
$198
$18.9 P/Share
|
|
Jun 20
2024
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+33.92%
|
-
|
|
Jun 20
2024
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,177
+29.23%
|
$133,947
$11.33 P/Share
|
|
Jun 20
2024
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+31.45%
|
-
|
|
Jun 20
2024
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+30.58%
|
-
|
|
Jun 20
2024
|
Elizabeth A. Geary Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,596
+44.05%
|
-
|
|
Mar 15
2024
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,409
-1.11%
|
$122,724
$36.61 P/Share
|
|
Mar 15
2024
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-1.67%
|
$4,824
$36.61 P/Share
|
|
Mar 15
2024
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.03%
|
$22,176
$36.61 P/Share
|
|
Mar 13
2024
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,565
+38.77%
|
-
|
|
Mar 13
2024
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,718
+30.2%
|
-
|
|
Mar 13
2024
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,087
+30.4%
|
-
|
|
Mar 08
2024
|
Scott Schlackman Director |
SELL
Open market or private sale
|
Direct |
4,053
-18.55%
|
$158,067
$39.43 P/Share
|
|
Mar 08
2024
|
Scott Schlackman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+9.9%
|
$35,100
$27.68 P/Share
|
|
Feb 14
2024
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
648
-5.36%
|
$33,696
$52.68 P/Share
|
|
Feb 14
2024
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,328
+16.16%
|
-
|
|
Feb 14
2024
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,471
-8.6%
|
$284,492
$52.68 P/Share
|
|
Feb 14
2024
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,486
+20.58%
|
-
|
|
Nov 07
2023
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
52
+0.49%
|
$3,536
$68.89 P/Share
|
|
Nov 07
2023
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
49
+0.58%
|
$3,332
$68.89 P/Share
|
|
Nov 07
2023
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
50
+0.79%
|
$3,400
$68.89 P/Share
|
|
Nov 07
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
58
+0.99%
|
$3,944
$68.89 P/Share
|
|
Nov 03
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
96
+2.22%
|
$6,720
$70.55 P/Share
|
|
Oct 06
2023
|
Constance J. Hallquist |
SELL
Open market or private sale
|
Indirect |
5,613
-72.29%
|
$409,749
$73.87 P/Share
|
|
Sep 13
2023
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.67%
|
$810
$81.08 P/Share
|
|
Aug 15
2023
|
Jeffrey J Brown Director |
SELL
Open market or private sale
|
Indirect |
23,162
-71.22%
|
$2,084,580
$90.13 P/Share
|
|
Aug 14
2023
|
Jeffrey J Brown Director |
SELL
Open market or private sale
|
Indirect |
15,154
-39.55%
|
$1,394,168
$92.6 P/Share
|
|
Aug 08
2023
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
37
+0.44%
|
$3,293
$89.42 P/Share
|
|
Aug 08
2023
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
38
+0.61%
|
$3,382
$89.42 P/Share
|
|
Aug 08
2023
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
39
+0.37%
|
$3,471
$89.42 P/Share
|
|
Aug 08
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
44
+0.76%
|
$3,916
$89.42 P/Share
|
|
Aug 04
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
688
+1.59%
|
$68,800
$100.03 P/Share
|
|
Jul 20
2023
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,142
-5.55%
|
$107,348
$94.5 P/Share
|
|
Jul 20
2023
|
James P. Maloney Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,574
+24.9%
|
-
|
|
Jun 15
2023
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,289
+36.67%
|
-
|
|
Jun 15
2023
|
Elizabeth A. Geary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,781
+50.0%
|
-
|
|
Jun 15
2023
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,152
+23.18%
|
-
|
|
Jun 15
2023
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,118
+33.59%
|
-
|
|
Jun 15
2023
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,118
+27.34%
|
-
|
|
May 09
2023
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
13
+0.18%
|
$1,131
$87.5 P/Share
|
|
May 09
2023
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
12
+0.39%
|
$1,044
$87.5 P/Share
|
|
May 09
2023
|
Constance J. Hallquist |
BUY
Open market or private purchase
|
Direct |
13
+0.17%
|
$1,131
$87.5 P/Share
|
|
May 09
2023
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
12
+0.23%
|
$1,044
$87.5 P/Share
|
|
May 09
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
15
+0.62%
|
$1,305
$87.5 P/Share
|
|
May 05
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
753
+1.77%
|
$67,017
$89.74 P/Share
|
|
Mar 17
2023
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
906
+37.72%
|
-
|
|
Mar 17
2023
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,574
+38.46%
|
-
|
|
Mar 17
2023
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-2.66%
|
$7,650
$102.75 P/Share
|
|
Mar 17
2023
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,807
+26.29%
|
-
|
|
Mar 17
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-2.8%
|
$88,944
$102.75 P/Share
|